Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation
WEFA
1 other identifier
observational
283
1 country
3
Brief Summary
The proposed clinical study aims to validate the diagnostic performance, compared to a reference ECG, of the ECG-SW1 software and the PPG-SW1 software integrated into the HWA09 watch developed by Withings for the automatic identification of atrial fibrillation (AF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2019
CompletedFirst Submitted
Initial submission to the registry
April 8, 2020
CompletedFirst Posted
Study publicly available on registry
April 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2021
CompletedNovember 16, 2021
November 1, 2021
1.3 years
April 8, 2020
November 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sensitivity of the automatic classification in AF by ECG-SW1 of HWA09 single-lead ECG against reference 12-lead ECG
sensitivity from the 2x2 confusion matrix AF vs 'non-AF'
1 year
Sensitivity of the automatic classification in NSR by ECG-SW1 of HWA09 single-lead ECG against reference 12-lead ECG
sensitivity from the 2x2 confusion matrix NSR vs 'non-NSR'
1 year
Secondary Outcomes (12)
Sensitivity of the automatic classification in AF by PPG-SW1 of the HWA09 PPG against reference 12-lead ECG
1 year
Sensitivity of the automatic classification in NSR by PPG-SW1 of the HWA09 PPG against reference 12-lead ECG
1 year
Sensitivity of the cardiologists' classification in AF from the HWA09 ECG
1 year
Sensitivity of the cardiologists' classification in SR from the HWA09 ECG
1 year
Accuracy of the visibility of P-waves of single-lead ECG from HWA09
1 year
- +7 more secondary outcomes
Study Arms (3)
Atrial Fibrillation (AF)
Patients diagnosed with AF during reference ECG
Normal Sinus Rhythm (NSR)
Patients with NSR during reference ECG
Other Arrythmia
Patients diagnosed with an arrhythmia other than AF during the reference ECG
Interventions
Recording PPG and single-lead ECG signals with the Withings HWA09 and ECG signal for the reference 12-lead ECG
Eligibility Criteria
Every eligible patient doing a medical examination at the investigation center will be asked to take part in the study.
You may qualify if:
- Individuals over 18yo
- Individuals who expressed their non-opposition to take part in the study
- Individuals affiliated to a social security system or eligible
You may not qualify if:
- Vulnerable individuals according to the regulation in force :
- Pregnant, parturient or breastfeeding women
- Individuals deprived of liberty by a court, medical or administrative order
- Individuals under 18yo
- Individuals legally protected or unable to express their non-opposition to take part in
- Individuals unaffiliated to or not beneficiary of a social security system
- Individuals who fit in multiple categories above
- Individuals having refused to take part in the study
- Individuals linguistically or mentally unable to express their non-opposition
- Individuals physically unable to wear a watch
- Individuals with an electrical pacing by a pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Withingslead
Study Sites (3)
Institut Cœur Paris Centre Turin
Paris, Île-de-France Region, 75008, France
Hopital Europeen Georges Pompidou
Paris, Île-de-France Region, 75015, France
Centre Cardiologique du Nord
Saint-Denis, Île-de-France Region, 93200, France
Related Publications (1)
Campo D, Elie V, de Gallard T, Bartet P, Morichau-Beauchant T, Genain N, Fayol A, Fouassier D, Pasteur-Rousseau A, Puymirat E, Nahum J. Atrial Fibrillation Detection With an Analog Smartwatch: Prospective Clinical Study and Algorithm Validation. JMIR Form Res. 2022 Nov 4;6(11):e37280. doi: 10.2196/37280.
PMID: 35481559DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
David CAMPO
Withings
- PRINCIPAL INVESTIGATOR
Julien NAHUM
Centre Cardiologique du Nord
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2020
First Posted
April 17, 2020
Study Start
December 20, 2019
Primary Completion
April 7, 2021
Study Completion
April 7, 2021
Last Updated
November 16, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
Individual patient data (IPD) are considered as confidential in this study. After the end the final quality control, the database will be frozen and all the IPD will be archived .